Eastling Thomas Wilson insider trades
Eastling Thomas Wilson has filed 5 Form 4s with the SEC that we hold, all for Gyre Therapeutics, INC. (GYRE), as Chief Financial Officer. None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2023-11-01 and the latest 2026-05-06.
Gyre Therapeutics, INC. (GYRE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1958487) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms